# Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension

> **NCT07290400** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Aspargo Labs, Inc** · enrollment: 36 (estimated)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Hezkue Sildenafil Oral Suspension
- **OTHER:** Moderate Alcohol Intake

## Key facts

- **NCT ID:** NCT07290400
- **Lead sponsor:** Aspargo Labs, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2026-06-15
- **Final completion:** 2026-06-28
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07290400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07290400, "Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT07290400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*